{"disease":{"id":"healthy-lactating-women","name":"healthy lactating women"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06021951","title":"Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) in the Breast Milk of Healthy Lactating Women","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Esperion Therapeutics, Inc.","has_results":true},{"nct_id":"NCT06259331","title":"Evaluation of Viloxazine and Its Metabolite 5-Hydroxy-viloxazine Glucuronide Into Breast Milk in Healthy Lactating Women","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Supernus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT05547100","title":"Study of the Breast Milk Pharmacokinetics of Olanzapine and Samidorphan","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Alkermes, Inc.","has_results":false},{"nct_id":"NCT04984759","title":"Tafenoquine and Primaquine in Colostrum and Breast Milk","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Oxford","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}